New Posts New Posts RSS Feed - Erilibulin Mesylate for advanced bc
  FAQ FAQ  Forum Search   Events   Register Register  Login Login

Erilibulin Mesylate for advanced bc

 Post Reply Post Reply
Author
trip2 View Drop Down
Senior Member
Senior Member
Avatar

Joined: Jun 03 2007
Location: Under Palm Tree
Status: Offline
Points: 8549
Post Options Post Options   Thanks (0) Thanks(0)   Quote trip2 Quote  Post ReplyReply Direct Link To This Post Topic: Erilibulin Mesylate for advanced bc
    Posted: May 31 2008 at 6:22am
http://www.eurekalert.org/pub_releases/2008-05/ei-emd051608.php
 
 
"Woodcliff Lake, N.J., May 15, 2008¡ªThe investigational chemotherapeutic agent eribulin mesylate (E7389) demonstrated activity in a heavily pretreated population of women with locally advanced or metastatic breast cancer, according to results of a multi-center Phase II clinical trial. The study also suggests that eribulin mesylate has a manageable tolerability profile, with a low incidence of Grade 3 (severe) and no Grade 4 (disabling or life-threatening) neuropathy. These data (abstract #1084) will be presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) on Monday, June 2 from 2 to 6 p.m. at S Hall A1 of McCormick Place"
Stage 2 2003
Stage 1 2007
BRCA 1+
Back to Top
 Post Reply Post Reply
  Share Topic   

Forum Jump Forum Permissions View Drop Down

Forum Software by Web Wiz Forums® version 12.01
Copyright ©2001-2018 Web Wiz Ltd.